Historical Valuation
Hologic Inc (HOLX) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.35 is considered Undervalued compared with the five-year average of 17.76. The fair price of Hologic Inc (HOLX) is between 97.02 to 121.46 according to relative valuation methord. Compared to the current price of 74.87 USD , Hologic Inc is Undervalued By 22.83%.
Relative Value
Fair Zone
97.02-121.46
Current Price：74.87
22.83%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Hologic Inc (HOLX) has a current Price-to-Book (P/B) ratio of 3.29. Compared to its 3-year average P/B ratio of 3.47 , the current P/B ratio is approximately -5.22% higher. Relative to its 5-year average P/B ratio of 3.80, the current P/B ratio is about -13.60% higher. Hologic Inc (HOLX) has a Forward Free Cash Flow (FCF) yield of approximately 5.54%. Compared to its 3-year average FCF yield of 5.94%, the current FCF yield is approximately -6.81% lower. Relative to its 5-year average FCF yield of 8.07% , the current FCF yield is about -31.43% lower.
P/B
Median3y
3.47
Median5y
3.80
FCF Yield
Median3y
5.94
Median5y
8.07
Competitors Valuation Multiple
AI Analysis for HOLX
The average P/S ratio for HOLX competitors is 4.61, providing a benchmark for relative valuation. Hologic Inc Corp (HOLX.O) exhibits a P/S ratio of 3.88, which is -15.95% above the industry average. Given its robust revenue growth of 6.23%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HOLX
1Y
3Y
5Y
Market capitalization of HOLX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HOLX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HOLX currently overvalued or undervalued?
Hologic Inc (HOLX) is now in the Undervalued zone, suggesting that its current forward PE ratio of 16.35 is considered Undervalued compared with the five-year average of 17.76. The fair price of Hologic Inc (HOLX) is between 97.02 to 121.46 according to relative valuation methord. Compared to the current price of 74.87 USD , Hologic Inc is Undervalued By 22.83% .
What is Hologic Inc (HOLX) fair value?
HOLX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Hologic Inc (HOLX) is between 97.02 to 121.46 according to relative valuation methord.
How does HOLX's valuation metrics compare to the industry average?
The average P/S ratio for HOLX's competitors is 4.61, providing a benchmark for relative valuation. Hologic Inc Corp (HOLX) exhibits a P/S ratio of 3.88, which is -15.95% above the industry average. Given its robust revenue growth of 6.23%, this premium appears unsustainable.
What is the current P/B ratio for Hologic Inc (HOLX) as of Jan 10 2026?
As of Jan 10 2026, Hologic Inc (HOLX) has a P/B ratio of 3.29. This indicates that the market values HOLX at 3.29 times its book value.
What is the current FCF Yield for Hologic Inc (HOLX) as of Jan 10 2026?
As of Jan 10 2026, Hologic Inc (HOLX) has a FCF Yield of 5.54%. This means that for every dollar of Hologic Inc’s market capitalization, the company generates 5.54 cents in free cash flow.
What is the current Forward P/E ratio for Hologic Inc (HOLX) as of Jan 10 2026?
As of Jan 10 2026, Hologic Inc (HOLX) has a Forward P/E ratio of 16.35. This means the market is willing to pay $16.35 for every dollar of Hologic Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Hologic Inc (HOLX) as of Jan 10 2026?
As of Jan 10 2026, Hologic Inc (HOLX) has a Forward P/S ratio of 3.88. This means the market is valuing HOLX at $3.88 for every dollar of expected revenue over the next 12 months.